Incidence of immunotherapy‐related hyperprogressive disease (HPD) across HPD definitions and cancer types in observational studies: A systematic review and meta‐analysis
Abstract Background While evidence of hyperprogressive disease (HPD) continues to grow, the lack of a consensual definition obscures a proper characterization of HPD incidence. We examined how HPD incidence varies by the tumor type or the type of definition used. Methods We searched PubMed, Embase,...
Main Authors: | Min Jeong Kim, Seung Pyo D. Hong, Yeonggyeong Park, Young Kwang Chae |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-02-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.6970 |
Similar Items
-
Hyperprogressive Disease (HPD) in Solid Tumours Receiving Immune Checkpoint Inhibitors in a Real-World Setting
by: Yada Kanjanapan MBBS, et al.
Published: (2023-10-01) -
HPD-induced reversal of chloroquine resistance of malaria
by: F. Sogandares-Bernal, et al.
Published: (1986-01-01) -
Application of HPD Model for Predicting Protein Mutations
by: Fidanova Stefka
Published: (2013-12-01) -
Case report: A combined immunotherapy strategy as a promising therapy for MSI-H colorectal carcinomas with multiple HPD risk factors
by: Jinli Zhang, et al.
Published: (2023-05-01) -
PD-L1 and IFN-γ modulate Non-Small Cell Lung Cancer (NSCLC) cell plasticity associated to immune checkpoint inhibitor (ICI)-mediated hyperprogressive disease (HPD)
by: Stefania Angelicola, et al.
Published: (2025-01-01)